发明授权
US07659281B2 HMG-CoA reductase inhibitors 有权
HMG-CoA还原酶抑制剂

HMG-CoA reductase inhibitors
摘要:
Compounds are provided of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia and dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis wherein variables A and B are defined herein.
公开/授权文献
信息查询
0/0